India's Richest People 2026 edition · 1 director · Source: Hurun India
- #678 Sunil Siddharth Lalbhai & Family ₹4,700 Cr
Revenue · FY 2025
₹136.8 Cr
▲ 3% YoY
Net profit · FY 2025
₹2.58 Cr
Net margin 1.9%
EBITDA · FY 2025
₹14.88 Cr
EBITDA margin 10.9%
Authorised capital
₹60 Cr
Registered with MCA
Paid-up capital
₹29.02 Cr
Issued & subscribed
Open charges
₹45 Cr
Satisfied ₹58.75 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
170
Provident fund records
About Atul Bioscience Limited
Data last updated:
Atul Bioscience Limited is a public limited company based in Atul, Gujarat, India, a subsidiary of Atul Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 May 1997 and has been in existence for over 29 years.
Its director Sunil Siddharth Lalbhai and Family is #678 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1997PLC032369. Its GSTIN is 24AACCA0331P1ZX (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹60 Cr and a paid-up capital of ₹29.02 Cr. It was formerly known as Atul Pharmaceuticals Limited. It is led by directors including Prabhakar Chebiyyam (Managing Director) and Rangaswamy Rathakrishnan Iyer.
Its last annual general meeting (AGM) was held on 10 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 12 East Site, Atul, Gujarat, India – 396020.
As per the financials filed for FY 2025, the company reported a revenue of ₹136.8 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.58 Cr (net margin 1.9%) and EBITDA of ₹14.88 Cr (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
The company has about 170 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Atul. As per MCA filings, the company has open charges of ₹45 Cr and satisfied charges of ₹58.75 Cr on record. Court records list 211 cases involving the company, including 211 filed against it; 6 cases are pending. The company has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹54.95 Cr; the latest was in February 2019. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Riddhi Lifesciences India Private Limited with revenue of ₹143.3 Cr. The company has 9 MSME Form 1 returns on record between 2020 and 2024, listing 248 overdue payments to 92 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atulbio.co.in.
Company Details of Atul Bioscience Limited
CIN U24230GJ1997PLC032369
Registration Number 032369
Incorporation Date 21 May 1997
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 10 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Atul Limited
Compliance Status Active Compliant
CIN History of Atul Bioscience Limited
Atul Bioscience has one previous CIN (Corporate Identification Number): U24230GJ1997PTC032369. The current CIN is U24230GJ1997PLC032369, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ1997PLC032369 | Current |
| U24230GJ1997PTC032369 | Previous |
Key People
Prabhakar Chebiyyam Managing Director Rangaswamy Rathakrishnan Iyer Director Latika Prakash Pradhan Director Recognitions & Rankings of Atul Bioscience
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressE – 12 East Site, Atul, Gujarat, India – 396020
- IndustryPharma, API Manufacturers
Comprehensive company report
Atul Bioscience Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Atul Bioscience Limited
Atul Bioscience operates one associated brand: Atul. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Fine chemicals are manufactured by Atul in Ahmedabad, India. | atul.co.in |
Business Activity of Atul Bioscience Limited
The main business activity of Atul Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Atul Bioscience Limited FY 2025 filings available
Atul Bioscience Limited reported revenue of ₹136.8 Cr (up 3% YoY) for FY 2025.
Revenue · FY 2025
₹136.8 Cr ▲ 3%
Net profit · FY 2025
₹2.58 Cr margin 1.9%
EBITDA · FY 2025
₹14.88 Cr margin 10.9%
Compounded Annual Growth Rate (CAGR) of Atul Bioscience Limited
Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 3%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 2%
5 years · compounded
▲ 3%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 3% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Atul Bioscience Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹14.88 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.58 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Atul Bioscience Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Atul Bioscience are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Atul Bioscience Limited
Atul Bioscience has 9 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rangaswamy Rathakrishnan Iyer | Director | 19 Jan 2011 | 15 Years 9 Months | Current |
| Latika Prakash Pradhan Also directs: Aragen Biologics Private Limited | Director | 22 Oct 2021 | 5 Years 0 Months | Current |
| Pramod Hari Lele Also directs: Tatvag Research Foundation, Healthbridge Advisors Private Limited, Valsad Institute of Medical Sciences Limited and 1 more | Director | 19 Jan 2011 | 15 Years 9 Months | Current |
| Prabhakar Chebiyyam Also directs: Atul Lifescience Limited, Atul Healthcare Limited | Managing Director | 11 Jul 2014 | 12 Years 3 Months | Current |
| Sunil Siddharth Lalbhai Also directs: Britannia Industries Ltd, The Bombay Dyeing and Manufacturing Company Limited, Amal Limited and 4 more | Director | 11 Dec 2008 | 17 Years 10 Months | Current |
| Astha Sunil Lalbhai Also directs: Atul Consumer Products Limited, Aagam Holdings Private Limited | Director | 12 Oct 2018 | 8 Years 0 Months | Current |
Showing 6 of 9 current directors. View all directors
Peer Comparison of Atul Bioscience Limited
Atul Bioscience Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riddhi Lifesciences India Private Limited | ₹143.3 Cr (FY 2025) | •••• | •••• | 210.0% | •••• | Anklesvar, Gujarat, India |
| Lyka Labs Limited Listed | ₹140.73 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Ankleshwar, Gujarat, India |
| Azico Biophore India Private Limited | ₹140.48 Cr (FY 2024) | •••• | •••• | 25.0% | •••• | Hyderabad, Telangana, India |
| Silicon Life Sciences Private Limited | ₹139.2 Cr (FY 2020) | •••• | •••• | 31.0% | •••• | Hyderabad, Telangana, India |
| Satyadeeptha Pharmaceuticals Limited | ₹138.74 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Humnabad, Karnataka, India |
| Atul Bioscience Limited this company | ₹136.8 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Atul, Gujarat, India |
| Lasa Laboratory Private Limited | ₹136.67 Cr (FY 2016) | •••• | •••• | 92.0% | •••• | Badlapur, Maharashtra, India |
| Corvine Chemicals and Pharmaceuticals Private Limited | ₹136.26 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Bidar, Karnataka, India |
| Kinvan Private Limited | ₹135.98 Cr (FY 2025) | •••• | •••• | 11959.0% | •••• | Solan, Himachal Pradesh, India |
| Fleming Laboratories Limited | ₹135.89 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Telangana, India |
| R.N. Laboratories Private Limited | ₹135.13 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Atul Bioscience by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Atul Bioscience Limited
Atul Bioscience Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells LLP | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Atul Bioscience Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Atul Bioscience Limited
Open charges
₹45 Cr
Satisfied charges
₹58.75 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2024 | Others | ₹40 Cr | Open |
| 07 Jun 2011 | Axis Bank Limited | ₹5 Cr | Open |
| 08 Mar 2019 | Others | ₹40 Cr | Satisfied |
| 25 Jul 2012 | Axis Bank Ltd | ₹7.5 Cr | Satisfied |
| 07 Jun 2011 | Axis Bank Limited | ₹11.25 Cr | Satisfied |
Total charge records: 5 View all charges
Deals & Funding of Atul Bioscience Limited
Atul Bioscience Limited has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹54.95 Cr; the latest was in February 2019.
Total deals
8
Funding rounds
6
Secondary share transfers
2
Disclosed funding
₹54.95 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2019 | Funding round | ₹30 Cr | Investors: Atul Limited |
| Jan 2019 | Funding round | ₹10 Cr | Investors: Atul Limited |
| Mar 2016 | Secondary share transfer | Undisclosed | Seller: Atul Limited |
| Oct 2015 | Funding round | ₹4.56 Cr | Investors: Atul Limited |
| Apr 2012 | Funding round | ₹2.5 Cr | Investors: Atul Limited |
Premium access
Full deal history
All 8 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Atul Bioscience Limited
Atul Bioscience Limited has 211 court cases on record: 211 filed against it. 6 cases are pending and 205 are disposed.
Total cases
211
Filed against the company
211
Pending
6
Disposed
205
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 207 | 207 | 6 |
| District courts | 4 | 4 | 0 |
Cases on record (5 of 211)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Arbitration matter | Filed against the company by M/S Terrier Security Services (India) Pvt. Ltd. | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
Premium access
Full case history
All 211 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Atul Bioscience Limited
Atul Bioscience Limited has 9 MSME Form 1 returns on record between 2020 and 2024, listing 248 overdue payments to 92 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 92)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Classic Exports | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Safe Care Corporation | •••• | •••• | •••• |
| Modern Industrial Equipments Private Limited | •••• | •••• | •••• |
| Elixir Engineering Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 9 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Atul Bioscience Limited
Atul Bioscience Limited has a workforce of 170 employees as of Apr 06, 2024.
Employee count
170
Active EPFO establishments
2
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Atul Bioscience Limited
Atul Bioscience Limited has 25 board changes on record since 1997: 9 appointments and 16 cessations. The latest: Jagdish Viswanath Dore was appointed as Additional Director on 17 Jan 2025.
AGM
Atul Bioscience Limited last Annual general meeting of members was held on 10 Jul 2025 as per latest MCA records.
Filing
Atul Bioscience Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited of Rs. 5.00 Cr registered on 07 Jun 2011 with Charge ID 10291318 was modified on 14 Feb 2025.
Appointed
Jagdish Viswanath Dore was appointed as Additional Director.
Charges
A charge with Others of Rs. 40.00 Cr registered on 05 Jul 2024 with Charge ID 100950233 was modified on 19 Sep 2024.
Charges
A charge with Others amounted to Rs. 40.00 Cr with Charge ID 100950233 was registered on 05 Jul 2024.
Ceased
Latika Prakash Pradhan ceased to be Additional Director.
Ceased
Vivek Yeshwant Gadre ceased to be Additional Director.
Ceased
Suresh Kalra ceased to be Cfo(Kmp).
Appointed
Vivek Yeshwant Gadre was appointed as Director.
Ceased
Sharat Rajendra Tripathi ceased to be Additional Director.
Ceased
Rajeev Kumar ceased to be Company Secretary.
28 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Atul Bioscience Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Atul Bioscience Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Atul Bioscience Limited
Atul Bioscience has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCA0331P1ZX | Gujarat | Active | 01 Jul 2017 |
| 27AACCA0331P1ZR | Maharashtra | Active | 01 Jan 2019 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Atul Bioscience Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Atul Bioscience Limited
Frequently Asked Questions about Atul Bioscience Limited
Atul Bioscience is an active public limited company based in Atul, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 May 1997 (29+ years old) and is registered under CIN U24230GJ1997PLC032369.
Atul Bioscience reported revenue of ₹136.8 Cr for FY 2025 (up 3% YoY).
Atul Bioscience has 9 current directors:
- Prabhakar Chebiyyam - Managing Director
- Rangaswamy Rathakrishnan Iyer - Director
- Latika Prakash Pradhan - Director
- Pramod Hari Lele - Director
- Sunil Siddharth Lalbhai - Director
- Astha Sunil Lalbhai - Director
- Jagdish Viswanath Dore - Additional Director
- Gopi Kannan Rengachari Thirukonda - Director
- Vivek Yeshwant Gadre - Director
Atul Bioscience reported a net profit of ₹2.58 Cr (net margin 1.9%) and EBITDA of ₹14.88 Cr (EBITDA margin 10.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Atul Bioscience is 3% over three years and 5% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Atul Bioscience is 24AACCA0331P1ZX, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AACCA0331P1ZR (Maharashtra).
The CIN (Corporate Identification Number) of Atul Bioscience is U24230GJ1997PLC032369. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atul Bioscience has 211 court cases on record: 211 filed against it. 6 are pending. Most are in the high courts.
Atul Bioscience was incorporated on 21 May 1997, making it 29+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Atul Bioscience has 8 deals on record (6 funding rounds, 2 secondary share transfers), with disclosed funding of ₹54.95 Cr; the latest was in February 2019.
The peers of Atul Bioscience by revenue are Riddhi Lifesciences India Private Limited, Lyka Labs Limited, Azico Biophore India Private Limited, Silicon Life Sciences Private Limited, Satyadeeptha Pharmaceuticals Limited and 5 more, all in the Pharma industry (API Manufacturers).
Jagdish Viswanath Dore was appointed as Additional Director on 17 Jan 2025. Latika Prakash Pradhan ceased to be Additional Director on 15 Jul 2022. Vivek Yeshwant Gadre ceased to be Additional Director on 15 Jul 2022. Atul Bioscience has 25 board changes on record in total.